Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy.
about
Chemotherapy-induced peripheral neurotoxicity and complementary and alternative medicines: progress and perspectiveMechanisms involved in the development of chemotherapy-induced neuropathyMechanisms of chemotherapy-induced behavioral toxicitiesAnimal models of peripheral neuropathy due to environmental toxicantsMitotoxicity in distal symmetrical sensory peripheral neuropathiesPaclitaxel-induced increase in mitochondrial volume mediates dysregulation of intracellular Ca2+ in putative nociceptive glabrous skin neurons from the ratPain in cancer survivorsNeurotoxicity to DRG neurons varies between rodent strains treated with cisplatin and bortezomib.Nerve growth factor alters microtubule targeting agent-induced neurotransmitter release but not MTA-induced neurite retraction in sensory neurons.Bioenergetic deficits in peripheral nerve sensory axons during chemotherapy-induced neuropathic pain resulting from peroxynitrite-mediated post-translational nitration of mitochondrial superoxide dismutase.EXPRESS: Methylcobalamin ameliorates neuropathic pain induced by vincristine in rats: Effect on loss of peripheral nerve fibers and imbalance of cytokines in the spinal dorsal horn.Nutraceuticals against Neurodegeneration: A Mechanistic Insight.Potential Therapeutic Benefits of Maintaining Mitochondrial Health in Peripheral Neuropathies.Chemotherapy-induced painful neuropathy: pain-like behaviours in rodent models and their response to commonly used analgesicsPathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN).Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy.Genetic inactivation and pharmacological blockade of sigma-1 receptors prevent paclitaxel-induced sensory-nerve mitochondrial abnormalities and neuropathic pain in mice.Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review.Rodent models of chemotherapy-induced peripheral neuropathy.Chemotherapy-induced peripheral neuropathies in hematological malignancies.Mechanisms of distal axonal degeneration in peripheral neuropathies.Kinesin-5 Blocker Monastrol Protects Against Bortezomib-Induced Peripheral Neurotoxicity.Chemotherapy-induced peripheral neuropathy: A current review.Bortezomib alters microtubule polymerization and axonal transport in rat dorsal root ganglion neurons.Melatonin pre-treatment mitigates SHSY-5Y cells against oxaliplatin induced mitochondrial stress and apoptotic cell death.A Mechanistic Understanding of Axon Degeneration in Chemotherapy-Induced Peripheral Neuropathy.An Overview of Bortezomib-Induced NeurotoxicityLow Neurotoxicity of ONX-0914 Supports the Idea of Specific Immunoproteasome Inhibition as a Side-Effect-Limiting, Therapeutic Strategy.Peripheral neuropathy induced by microtubule-targeted chemotherapies: insights into acute injury and long-term recovery.Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN).Characterization of a rat model of bortezomib-induced painful neuropathy.Pharmacological augmentation of nicotinamide phosphoribosyltransferase (NAMPT) protects against paclitaxel-induced peripheral neuropathy.Pharmacotherapy options for managing chemotherapy-induced peripheral neurotoxicity.An Orally Active Epac Inhibitor Reverses Mechanical Allodynia and Loss of Intraepidermal Nerve Fibers \iIn A Mouse Model of Chemotherapy-Induced Peripheral Neuropathy.Oxaliplatin-induced enteric neuronal loss and intestinal dysfunction is prevented by co-treatment with BGP-15.Neuroprotective activities of curcumin and quercetin with potential relevance to mitochondrial dysfunction induced by oxaliplatin.α-Spinasterol: a COX inhibitor and a transient receptor potential vanilloid 1 antagonist presents an antinociceptive effect in clinically relevant models of pain in mice.Bortezomib induces neuropathic pain through protein kinase C-mediated activation of presynaptic NMDA receptors in the spinal cord.Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx®): a placebo-controlled randomised phase II study (PLIANT).Neuropathic Pain: Delving into the Oxidative Origin and the Possible Implication of Transient Receptor Potential Channels.
P2860
Q26777967-352601E6-B2B4-426C-AC30-2F03DF15547FQ26824380-34822DD0-F8F4-4EC3-A6CE-001BC5715B7CQ26998870-1BCEE2D4-911E-4407-87A0-38448BD96734Q28394003-4D093F5B-A603-4463-8D5D-B192409EDD75Q28834071-5E75FD79-6EAB-4870-8746-87C80086CA0CQ29248252-29DF1420-79EE-4934-9E8F-EFD1E3A24E0BQ33650576-28B43636-C47E-42D0-9A06-6558375930FFQ36655166-D1AF7BDC-5A5B-4CF0-8EF5-262EEE881E96Q36884527-33A57A4E-A60E-461A-8CDF-E2487238BB38Q36909043-5F0D047C-C234-4C4C-8621-B0B7B6660D7AQ37114802-CF28EEF5-6833-4984-9637-5478E664C612Q37168739-A3398B77-0C71-442B-82D7-E9CEFB7A027DQ37168753-147B6911-558F-448C-8B6A-3A51A2D5568DQ37170634-7698ED6D-2AF6-41E3-9C35-A9868C541D23Q37399781-1DA9B193-2F17-44C8-B295-90F8221E53A4Q37541146-3EF3EED2-0842-4411-B373-4890A249EF9EQ37583394-3237E0F6-2014-4BBC-9BA8-7D350E1FB2F7Q37662576-516DEB64-3795-4238-B882-4F6A3A5092DCQ38194947-CF215E89-56E8-4D65-A486-C867E816D139Q38261204-E68C4D68-1467-4F45-AD62-CBBA15C597ABQ38330759-9B437DA9-0FA9-4AFC-9EEF-2C8A51650AAAQ38726608-CF1032DB-4C37-44F4-9F7E-7776BC861E97Q39293928-A86F42F7-0A0C-4266-A852-85D5E3E7E143Q39350414-3174B56B-6962-4696-BBD1-08D10CB02719Q41090119-65363BFA-BDC7-4227-BF44-DE2C85B725B2Q41606031-F2223A5D-8653-45D8-B5E9-2A561D0DFB1EQ42361419-F5272666-B8CC-4230-A111-638CAE21210AQ42372836-F559F90F-D91D-4E46-A1E3-EC3BE4DF45D1Q46235962-BEE0B6BA-32D3-4D39-9644-02AE98E77490Q46719997-61452E6E-FAE8-4252-BBD3-3093E8D87299Q47120603-EA809665-8DC8-4894-B685-E399068C5936Q47151258-C1B9572E-91E0-4E90-A138-199F28B8C345Q47344383-3089348B-D635-4E82-BE50-AF61F63FBC56Q47549123-F54B2E02-5D5B-447A-8EE8-EC2A7068FB7DQ47773940-7D733F36-AD9C-4463-8319-743146FC5888Q48155275-AFC0F55C-26B9-415B-954F-A1D571335A14Q48164902-DEA05B17-8134-4025-AD8A-5910257788A7Q48737325-5D173D9E-31DA-48A9-A8AB-46264251F223Q50002199-B2DA5737-5727-4796-928F-D5E9C9EC7B88Q50319836-DAC992DA-934A-4454-8F14-4BDAD43F8EAB
P2860
Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy.
@en
Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy.
@nl
type
label
Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy.
@en
Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy.
@nl
prefLabel
Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy.
@en
Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy.
@nl
P2093
P1476
Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy.
@en
P2093
P304
P356
10.1016/J.EXPNEUROL.2012.08.023
P407
P577
2012-08-28T00:00:00Z